Concepedia

Polina German

PG

Statistics

Publications

29

Citations

2.8K

H-Index

22

Active since

2009

Affiliations

Gilead Sciences (United States)(Current)

University of California, San Francisco

University of Pennsylvania

The University of Texas MD Anderson Cancer Center

Stanford University

Polina German is an author at Gilead Sciences (United States) specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

2009–2024

29

Publications

29

Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1

Susanna Naggie, Curtis Cooper, Michael S. Saag et al. · New England Journal of Medicine · 2015 · 463 citations · Full text

Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma

Lijun Zhou, Xian-De Liu, Mingli Sun et al. · Oncogene · 2015 · 386 citations · Full text

, , +8

Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID‐19, in Healthy Subjects

Rita Humeniuk, Anita Mathias, Huyen Cao et al. · Clinical and Translational Science · 2020 · 261 citations · Full text

Pharmacokinetics and Pharmacodynamics of GS-9350: A Novel Pharmacokinetic Enhancer Without Anti-HIV Activity

Anita Mathias, Polina German, Bernard P. Murray et al. · Clinical Pharmacology & Therapeutics · 2009 · 206 citations

The safety and effectiveness of ledipasvir−sofosbuvir in adolescents 12‐17 years old with hepatitis C virus genotype 1 infection

William F. Balistreri, Karen F. Murray, Philip Rosenthal et al. · Hepatology · 2016 · 195 citations · Full text

Rows per page

1–5 of 29